Status:
COMPLETED
Prophylactic Antibiotics in Measles
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
Medical Research Council Unit, The Gambia
Conditions:
Post-Measles Pneumonia
Measles
Eligibility:
All Genders
3+ years
Phase:
PHASE3
Brief Summary
Objective It is the objective to test whether the use of prophylactic antibiotics in measles infection will reduce the incidence of post-measles pneumonia and/or admissions to hospital with 50%. The p...
Detailed Description
Background The case-fatality rate of measles in developing countries is still high, particularly in infants. It is estimated that measles is responsible for more than one million deaths per year, and ...
Eligibility Criteria
Inclusion
- A clinical diagnosis of probable measles in the prodromal phase or within the first seven days of the onset of the rash
Exclusion
- Pregnant and nursing women
- Children less than 2 months old
- Children who need urgent referral to the hospital, children with bacterial infections of the lung, or children with another bacterial infection requiring systemic antibiotic treatment.
Key Trial Info
Start Date :
January 1 1998
Trial Type :
INTERVENTIONAL
End Date :
October 1 2001
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT00168532
Start Date
January 1 1998
End Date
October 1 2001
Last Update
February 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Apartado 861, Guinea-Bissau, 1004 Bissau Codex